Body Mass Index as a Predictive Factor of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

被引：0
|
作者：
Bellet Ezquerra, M. [1 ]
Perez Garcia, J. M. [1 ]
Munoz Couselo, E. [1 ]
SauraManich, C. [1 ]
Gomez Pardo, P. [1 ]
Vidal, M. [1 ]
Argiles, G. [1 ]
De Mattos, L. [1 ]
Cortes Castan, J. [1 ]
Baselga Torres, J. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Catalunya, Spain
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P4-03-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-03-04
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy
    Li, Yan-Ling
    Zhang, Xiao-Peng
    Li, Jie
    Cao, Kun
    Cui, Yong
    Li, Xiao-Ting
    Sun, Ying-Shi
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (02) : 242 - 249
  • [32] Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
    Ramirez-Tortosa, Cesar L.
    Alonso-Calderon, Ruben
    Maria Galvez-Navas, Jose
    Perez-Ramirez, Cristina
    Luis Quiles, Jose
    Sanchez-Rovira, Pedro
    Jimenez-Morales, Alberto
    Ramirez-Tortosa, Mcarmen
    CANCERS, 2022, 14 (21)
  • [33] The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
    Jiaqiang Dan
    Jinya Tan
    Junhua Huang
    Xiaoli Zhang
    Yao Guo
    Yunkun Huang
    Jin Yang
    Breast Cancer, 2020, 27 : 982 - 988
  • [34] The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients
    Dan, Jiaqiang
    Tan, Jinya
    Huang, Junhua
    Zhang, Xiaoli
    Guo, Yao
    Huang, Yunkun
    Yang, Jin
    BREAST CANCER, 2020, 27 (05) : 982 - 988
  • [35] Predictive factors for complete pathological response in hormone receptor-negative breast cancer patients undergoing neoadjuvant chemotherapy
    Dimitrov, George
    Troianova, Petranka
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 254
  • [36] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [37] Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian
    Krishnamurti, Uma
    Bhattarai, Shristi
    Klimov, Sergey
    Reid, Michelle
    Aneja, Ritu
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [38] An Overview of the Impact of Body Mass Index on Pathological Complete Response Following Neoadjuvant Chemotherapy in Operable Breast Cancer in a Tertiary Care Centre in South India
    Somashekhar, S. P.
    Jaiswal, Richa
    Kumar, Rohit
    Ashok, B. C.
    Rakshit, Susmita
    Rauthan, Amit
    Patil, Poonam
    Yashas, Nitin
    Karthik, H. K.
    Prasad, Archa
    Islam, Herra
    Ashwin, K. R.
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (03) : 271 - 278
  • [39] Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
    Asaoka, Mariko
    Narui, Kazutaka
    Suganuma, Nobuyasu
    Chishima, Takashi
    Yamada, Akimitsu
    Sugae, Sadatoshi
    Kawai, Saori
    Uenaka, Natsuki
    Teraoka, Saeko
    Miyahara, Kana
    Kawate, Takahiko
    Sato, Eichi
    Nagao, Toshitaka
    Matsubara, Yuka
    Gandhi, Shipra
    Takabe, Kazuaki
    Ishikawa, Takashi
    EJSO, 2019, 45 (12): : 2289 - 2294
  • [40] Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy
    Iwamoto, Naoko
    Aruga, Tomoyuki
    Horiguchi, Shinichiro
    Saita, Chiaki
    Onishi, Mai
    Goto, Risa
    Ishiba, Toshiyuki
    Honda, Yayoi
    Miyamoto, Hiromi
    Kuroi, Katsumasa
    SURGERY TODAY, 2020, 50 (02) : 178 - 184
12345